Stealth Liposomes and Cancer Targeting: A Realistic Compromise in Drug Delivery
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 5 (4) , 705-710
- https://doi.org/10.3109/08982109509012674
Abstract
(1995). Stealth Liposomes and Cancer Targeting: A Realistic Compromise in Drug Delivery. Journal of Liposome Research: Vol. 5, No. 4, pp. 705-710.Keywords
This publication has 10 references indexed in Scilit:
- Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak basesPublished by Elsevier ,2003
- Development of anti-p185HER2 immunoliposomes for cancer therapy.Proceedings of the National Academy of Sciences, 1995
- Antibody-Mediated Targeting of Long-Circulating (StealthR) LiposomesJournal of Liposome Research, 1994
- Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature.Proceedings of the National Academy of Sciences, 1993
- Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.Proceedings of the National Academy of Sciences, 1991
- Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.Proceedings of the National Academy of Sciences, 1988
- An Improved Method for in Vivo Tracing and Imaging of Liposomes Using a Gallium 67-Deferoxamine ComplexJournal of Liposome Research, 1988
- Targeting of Liposomes to Tumor Cells in VivoaAnnals of the New York Academy of Sciences, 1987
- New Methodology for Liposome Targeting to Specific CellsAnnals of the New York Academy of Sciences, 1985
- Targeting of drugsNature, 1977